U.S. flag

An official website of the United States government

NM_000465.4(BARD1):c.1977A>G (p.Arg659=) AND Malignant tumor of breast

Germline classification:
Likely benign (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001357201.5

Allele description [Variation Report for NM_000465.4(BARD1):c.1977A>G (p.Arg659=)]

NM_000465.4(BARD1):c.1977A>G (p.Arg659=)

Gene:
BARD1:BRCA1 associated RING domain 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_000465.4(BARD1):c.1977A>G (p.Arg659=)
Other names:
p.R659R:AGA>AGG
HGVS:
  • NC_000002.12:g.214730435T>C
  • NG_012047.3:g.84277A>G
  • NM_000465.4:c.1977A>GMANE SELECT
  • NM_001282543.2:c.1920A>G
  • NM_001282545.2:c.624A>G
  • NM_001282548.2:c.567A>G
  • NM_001282549.2:c.438A>G
  • NP_000456.2:p.Arg659=
  • NP_001269472.1:p.Arg640=
  • NP_001269474.1:p.Arg208=
  • NP_001269477.1:p.Arg189=
  • NP_001269478.1:p.Arg146=
  • LRG_297t1:c.1977A>G
  • LRG_297:g.84277A>G
  • LRG_297p1:p.Arg659=
  • NC_000002.11:g.215595159T>C
  • NG_012047.2:g.84270A>G
  • NM_000465.2:c.1977A>G
  • NM_000465.3:c.1977A>G
  • NR_104212.2:n.1942A>G
  • NR_104215.2:n.1885A>G
  • NR_104216.2:n.1141A>G
  • p.Arg659Arg
  • p.R659R
Links:
dbSNP: rs147215925
NCBI 1000 Genomes Browser:
rs147215925
Molecular consequence:
  • NR_104212.2:n.1942A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104215.2:n.1885A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104216.2:n.1141A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_000465.4:c.1977A>G - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001282543.2:c.1920A>G - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001282545.2:c.624A>G - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001282548.2:c.567A>G - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001282549.2:c.438A>G - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
Malignant tumor of breast
Synonyms:
Malignant breast neoplasm; Cancer breast
Identifiers:
MONDO: MONDO:0007254; MedGen: C0006142

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001552590Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)

See additional submitters

no assertion criteria provided
Likely benignunknownclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV001552590.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The BARD1 p.Arg659= variant was identified in 50 of 25,074 proband chromosomes (frequency: 0.002) from individuals or families with basal cell carcinoma and hereditary breast and ovarian cancer and was present in 14 of 9414 control chromosomes (frequency: 0.001) from healthy individuals (Suszynska 2019, Cho 2018). The variant was identified in dbSNP (rs147215925) as “with other allele” and ClinVar (classified as likely benign by GeneDx, Ambry Genetics, Mendelics and 4 other submitters, benign by Invitae, Color and Quest Diagnostics and uncertain significance by Integrated Genetics and Prevention Genetics). The variant was identified in control databases in 576 of 282,800 chromosomes (1 homozygous) at a frequency of 0.002 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Ashkenazi Jewish in 81 of 10,366 chromosomes (freq: 0.008), Other in 24 of 7216 chromosomes (freq: 0.003), European in 398 of 129,128 chromosomes (freq: 0.003), Finnish in 33 of 25,118 chromosomes (freq: 0.001), Latino in 30 of 35,438 chromosomes (freq: 0.0008), African in 9 of 24,968 chromosomes (freq: 0.0004), South Asian in 1 of 30,612 chromosomes (freq: 0.00003), while the variant was not observed in the East Asian population. The p.Arg659= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. The variant occurs at a non-highly conserved nucleotide outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024